Inventor · disambiguated record
Tomofumi Kurokawa
Also filed as: KUROKAWA TOMOFUMI
5 granted patents·7 pending applications·490 citations·filing 1994–2022
86Inventor score
Files withTAKEDA CHEMICAL INDUSTRIES LTD5HASHIMOTO JUN1INOOKA HIROSHI1TAISHO PHARMACEUTICAL CO LTD1TAKEDA PHAMARMACEUTICAL COMPAN1
Top patents by PatentIndex Score
12 records- 0193US6117455ASustained-release microcapsule of amorphous water-soluble pharmaceutical active agentTAKEDA CHEMICAL INDUSTRIES LTD·Filed 1995·Granted Sep 12, 2000·200 cites·42 claims
- 0291US6190702B1Sustained-released material prepared by dispersing a lyophilized polypeptide in an oil phaseTAKEDA CHEMICAL INDUSTRIES LTD·Filed 1997·Granted Feb 20, 2001·98 cites·33 claims
- 0387US5496549ABispecific monoclonal antibodies, thrombolytic agent and method of cell lysisTAKEDA CHEMICAL INDUSTRIES LTD·Filed 1994·Granted Mar 5, 1996·112 cites·13 claims
- 0484US5876756AMicrocapsule containing amorphous water-soluble 2-piperazinone-1-acetic acid compoundTAKEDA CHEMICAL INDUSTRIES LTD·Filed 1996·Granted Mar 2, 1999·78 cites·32 claims
- 0558US2024391996A1Anti-growth hormone antibodyTAISHO PHARMACEUTICAL CO LTD·Filed 2022·Application pending·0 cites
- 0651US2001006678A1Sustained-release material prepared by dispersing a lyophilized polypeptide in an oil phaseFiled 2001·Application pending·0 cites
- 0746US2003175808A1Novel protein and dna thereofFiled 2001·Application pending·0 cites
- 0844US2009263840A1Novel Monoclonal Anitbody and Use thereofHASHIMOTO JUN·Filed 2006·Application pending·0 cites
- 0944US2010008928A1Agent for preventing/treating cancerTAKEDA PHAMARMACEUTICAL COMPAN·Filed 2007·Application pending·0 cites
- 1043US2009142346A1Preventive/Remedy for CancerTAKEDA PHARMACEUTICAL·Filed 2006·Application pending·0 cites
- 1138US2007202099A1Antibody DrugINOOKA HIROSHI·Filed 2005·Application pending·0 cites
- 1232US5506135AHybrid monoclonal antibodies, their production and useTAKEDA CHEMICAL INDUSTRIES LTD·Filed 1994·Granted Apr 9, 1996·2 cites·3 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →